Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model
Atherosclerosis may lead to cardiovascular diseases (CVD), which are the primary cause of death globally. In addition to conventional therapeutics for CVD, use of nutraceuticals that prevents cholesterol deposition, reduce existing plaques and hence anti-atherosclerotic effects of nutraceuticals app...
Main Authors: | Sanaa Almowallad, Etimad Huwait, Rehab Al-Massabi, Salma Saddeek, Kalamegam Gauthaman, Alexandre Prola |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/11/372 |
Similar Items
-
Punicalagin Targets Atherosclerosis: Gene Expression Profiling of THP-1 Macrophages Treated with Punicalagin and Molecular Docking
by: Etimad Huwait, et al.
Published: (2022-05-01) -
Thymoquinone (TQ) Inhibits Inflammation and Migration of THP-1 Macrophages: Mechanistic Insights into the Prevention of Atherosclerosis Using In-Vitro and In-Silico Analysis
by: Etimad Huwait, et al.
Published: (2022-04-01) -
Atheroprotective Effect of Fucoidan in THP-1 Macrophages by Potential Upregulation of ABCA1
by: Zeenat Mirza, et al.
Published: (2023-10-01) -
Punicalagin, a pomegranate compound, induces apoptosis and autophagy in acute leukemia
by: Paweena Subkorn, et al.
Published: (2021-11-01) -
Antibiofilm effects of punicalagin against Staphylococcus aureus in vitro
by: Yunfeng Xu, et al.
Published: (2023-04-01)